Enterobacterial analysis as the biomarker for the inflammatory bowel disease

Enterobacterial analysis as the biomarker for the inflammatory bowel disease - Enterobacterial analysis as the biomarker for the inflammatory bowel disease

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000034001

Enrollment

Registered

2018-09-03

Start date

2017-09-22

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Inflammatory bowel disease

Interventions

Collection the fecal samples

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: IBD patients More than 20 years old

Exclusion criteria

Exclusion criteria: 1. Patients with severe situation 2. patients with pregnancy 3. Patients taking anticoagulant. 4. Patient who doctors realize inappropriate for this study.

Design outcomes

Primary

Measure	Time frame
We compare laboratory data, clinical conditions and endoscopic findings one-year after entry with patient' enterobacteria, and we identify the enterobacteria which correlate with clinical conditions and endoscopic findings.	—

Countries

Japan

Contacts

Public ContactKoki Okahara

Juntendo University Gastroenterology

k-okahara@juntendo.ac.jp0338133111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026